Cargando…

Carfilzomib’s Real-World Safety Outcomes in Korea: Target Trial Emulation Study Using Electronic Health Records

Carfilzomib is a promising anticancer drug for relapsed/refractory multiple myeloma (RRMM). However, real-world evidence has only investigated the cardiovascular safety of carfilzomib, and there is a high demand for thorough safety evaluations. We aimed to comprehensively evaluate the risk of advers...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jang, Ha Young, Lee, Hyun Kyung, Kim, Chae Jeong, Yoon, Sung-Soo, Kim, In-Wha, Oh, Jung Mi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603615/ https://www.ncbi.nlm.nih.gov/pubmed/36294140 http://dx.doi.org/10.3390/ijerph192013560

Ejemplares similares

Using real-world data for supporting regulatory decision making: Comparison of cardiovascular and safety outcomes of an empagliflozin randomized clinical trial versus real-world data
por: Jang, Ha Young, et al.
Publicado: (2022)

Emulating Control Arms for Cancer Clinical Trials Using External Cohorts Created From Electronic Health Record‐Derived Real‐World Data
por: Tan, Katherine, et al.
Publicado: (2021)

Real-world data emulating randomized controlled trials of non-vitamin K antagonist oral anticoagulants in patients with venous thromboembolism
por: Yoon, Dongwon, et al.
Publicado: (2023)

Patient Visits and Prescribing Patterns Associated with Rosacea in Korea: A Real-World Retrospective Study Based on Electronic Medical Records
por: Woo, Yu Ri, et al.
Publicado: (2022)

Real-world effectiveness and safety analysis of carfilzomib–lenalidomide–dexamethasone and carfilzomib–dexamethasone in relapsed/refractory multiple myeloma: a multicenter retrospective analysis
por: Onda, Yoshiyuki, et al.
Publicado: (2022)

The Adoption of Electronic Medical Records and Decision Support Systems in Korea
por: Chae, Young Moon, et al.
Publicado: (2011)

Optimizing carfilzomib use in multiple myeloma treatment
por: Yoon, Sung-Soo
Publicado: (2019)

Weight Change and the Onset of Cardiovascular Diseases: Emulating Trials Using Electronic Health Records
por: Katsoulis, Michail, et al.
Publicado: (2021)

Real-World Evidence of Point-of-Care Glucometers: Enhanced Passive Surveillance and Adverse Event Reporting Status in Korea and the United States
por: Choi, Sooin, et al.
Publicado: (2023)

Real‐world use of carfilzomib combined with lenalidomide and dexamethasone in patients with multiple myeloma in Europe and Israel
por: Leleu, Xavier, et al.
Publicado: (2022)

Real-World Use and Effectiveness of Carfilzomib Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma in Europe
por: Terpos, Evangelos, et al.
Publicado: (2022)

Comparative Safety Analysis of Empagliflozin in Type 2 Diabetes Mellitus Patients with Chronic Kidney Disease versus Normal Kidney Function: A Nationwide Cohort Study in Korea
por: Jang, Ha Young, et al.
Publicado: (2023)

Real-World Accuracy of a SARS-CoV-2 Rapid Diagnostic Tests in the Republic of Korea
por: Kweon, Oh Joo, et al.
Publicado: (2022)

Emulating the GRADE trial using real world data: retrospective comparative effectiveness study
por: Deng, Yihong, et al.
Publicado: (2022)

Real‐world experience of carfilzomib‐associated cardiovascular adverse events: SEER‐Medicare data set analysis
por: Bishnoi, Rohit, et al.
Publicado: (2020)

Carfilzomib-Based Regimen and Cardiotoxicity in Multiple Myeloma: Incidence of Cardiovascular Events and Organ Damage in Carfilzomib-Dexamethasone versus Carfilzomib-Lenalidomide-Dexamethasone. A Real-Life Prospective Study
por: Astarita, Anna, et al.
Publicado: (2023)

1806. The gap in the amount of monthly antimicrobial use according to the data source: Electronic Health Record Data vs. National Health Insurance Claim Data in Korea
por: Kim, Bongyoung, et al.
Publicado: (2022)

The burden of symptomatic patients with chronic spontaneous urticaria: a real-world study in Korea
por: Ye, Young-Min, et al.
Publicado: (2022)

Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea
por: Lim, Sun Min, et al.
Publicado: (2020)

From real-world electronic health record data to real-world results using artificial intelligence
por: Knevel, Rachel, et al.
Publicado: (2023)

Emulation of the control cohort of a randomized controlled trial in pediatric kidney transplantation with Real-World Data from the CERTAIN Registry
por: Patry, Christian, et al.
Publicado: (2022)

emulator
Publicado: (1999)

Emulation
por: Powell, T. S.
Publicado: (1878)

The real-world outcomes of vedolizumab in patients with ulcerative colitis in Korea: a multicenter retrospective study
por: Ye, Byong Duk, et al.
Publicado: (2021)

The Impact of National Surveillance for Liver Cancer: Results from Real-World Setting in Korea
por: Kwon, Jin Won, et al.
Publicado: (2020)

Data collection framework for electronic medical record-based real-world data to evaluate the effectiveness and safety of cancer drugs: a nationwide real-world study of the Korean Cancer Study Group
por: Han, Hye Sook, et al.
Publicado: (2022)

Cardiovascular Toxicity of Carfilzomib: The Real-World Evidence Based on the Adverse Event Reporting System Database of the FDA, the United States
por: Zhai, Yinghong, et al.
Publicado: (2021)

Real-world Evidence versus Randomized Controlled Trial: Clinical Research Based on Electronic Medical Records
por: Kim, Hun-Sung, et al.
Publicado: (2018)

Final analysis of carfilzomib, dexamethasone, and daratumumab vs carfilzomib and dexamethasone in the CANDOR study
por: Usmani, Saad Z., et al.
Publicado: (2023)

Real-world experience of afatinib as first-line therapy for advanced EGFR mutation-positive non-small cell lung cancer in Korea
por: Lee, Sung Yong, et al.
Publicado: (2021)

Real-World Effectiveness, Tolerability, and Safety of Dolutegravir/Lamivudine in Korea
por: Lee, Ki Hyun, et al.
Publicado: (2022)

Oncology Drug Effectiveness from Electronic Health Record Data Calibrated Against RCT Evidence: The PARSIFAL Trial Emulation
por: Merola, David, et al.
Publicado: (2022)

Real-world management of chronic myeloid leukemia in South Korea: the TARGET survey
por: Uhm, Jieun, et al.
Publicado: (2021)

Real-world treatment patterns for atopic dermatitis in South Korea
por: Lee, Ji Hyun, et al.
Publicado: (2022)

A real-world comparative analysis of carfilzomib and other systemic multiple myeloma chemotherapies in a US community oncology setting
por: Rifkin, Robert M., et al.
Publicado: (2019)

Methodology and results of real-world cost-effectiveness of carfilzomib in combination with lenalidomide and dexamethasone in relapsed multiple myeloma using registry data
por: Campioni, M., et al.
Publicado: (2019)

Once weekly selinexor, carfilzomib and dexamethasone in carfilzomib non-refractory multiple myeloma patients
por: Gasparetto, Cristina, et al.
Publicado: (2021)

Emulators terminal
Publicado: (2016)

Real-World Management of Hyperkalemia in the Emergency Department: An Electronic Medical Record Analysis
por: Davis, Jill, et al.
Publicado: (2021)

Identification of delirium from real-world electronic health record clinical notes
por: St. Sauver, Jennifer, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mjolair1pedg662h5tt70sieir